Bladder Cancer

Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer? - Beyond the Abstract July 28, 2019

Biological Molecular Layer Classification of Muscle-Invasive Bladder Cancer Opens New Treatment Opportunities - Beyond the Abstract July 28, 2019

Epidermal Growth Factor Receptor Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression - Beyond the Abstract July 12, 2019

Small Cell Neuroendocrine Bladder Cancer: An Organ-specific Perspective - Beyond the Abstract June 24, 2019

Cystoscopy Real-Time Self-Visualization and Its Impact in Patient's Pain Perception - Beyond the Abstract June 4, 2019

New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins - Beyond the Abstract June 4, 2019

The Value of Immediate Postoperative Intravesical Epirubicin Instillation as an Adjunct to Standard Adjuvant Treatment in Intermediate and High-risk NMIBC - Beyond the Abstract May 16, 2019

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma – Beyond the Abstract May 16, 2019

The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics - Beyond the Abstract May 8, 2019

Tumor Immune Microenvironment Drives Prognostic Relevance Correlating with Bladder Cancer Subtypes – Beyond the Abstract April 28, 2019

Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation. - Beyond the Abstract March 28, 2019

Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer - Beyond the Abstract March 26, 2019

Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? - Beyond the Abstract February 22, 2019

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy - Beyond the Abstract February 22, 2019

The Development of Interferon-Based Gene Therapy for BCG Unresponsive Bladder Cancer: From Bench to Bedside – Beyond the Abstract February 6, 2019

Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios - Beyond the Abstract January 16, 2019

A Risk-Stratified Approach to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Implications for Patients Classified with Low-risk Disease - Beyond the Abstract January 15, 2019

Molecular Footprints of Muscle-Invasive Bladder Cancer in Smoking and Nonsmoking Patients - Beyond the Abstract December 10, 2018

Transcriptomic and Protein Analysis of Small Cell Bladder Cancer Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target - Beyond the Abstract December 9, 2018

Implications of Micropapillary Urothelial Carcinoma Variant on Prognosis Following Radical Cystectomy: A Multi-Institutional Investigation – Beyond the Abstract December 9, 2018

Page 1 of 12

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.